|
Vasomedical, Inc. - Comparative Business Analysis Snapshot
Business Description
Vasomedical, Inc.. The Group's principal activities are designing, manufacturing, marketing and support EECP (R) enhanced external counterpulsation system based on proprietary technology currently indicated for use in cases of stable and unstable angina ( chest pain ), congestive heart failure (CHF), acute myocardial infaction (heart attack) and cardiogenic shock. The products of the Group are sold to treatment providers in the United States through a direct sales force. The Group also provide hospitals, clinics and physician private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes.
Competitor Analysis
This analysis compares Vasomedical, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
